Oct 14, 2026 · 1h 7m
Listen from 3:02
Listen at 3:02
Dense breasts can hide cancer at any age
Why Younger Women Are Getting Breast Cancer at Record Rates (And How to Reduce Your Risk)
The conversation argues that breast cancer prevention depends on individualized risk assessment and broader women’s health care, not family history alone.
- 1Dense breast tissue can obscure mammograms, making risk-based use of 3D and additional imaging important.
- 2Lifetime-risk calculations and genetic testing can guide screening without automatically requiring preventive surgery.
- 3Metabolic health, environmental exposures, dismissed symptoms, and individualized hormone decisions all shape women’s cancer and reproductive health.
Don't miss
Thaïs Aliabadi recounts how imaging failed to identify her cancer and how atypical cells led her to calculate her own risk and choose a double mastectomy.
The brief
Thaïs Aliabadi joins Mark Hyman to challenge the idea that breast cancer mainly threatens women with family history or BRCA variants.
Aliabadi explains how dense breasts can conceal tumors on mammograms, making breast-density reporting, 3D imaging, and lifetime-risk assessment central to screening decisions.
Her own missed diagnosis becomes the episode’s sharpest example: atypical cells prompted further risk calculation, surgery, complications, and eventually a double mastectomy.
The discussion widens from cancer detection to metabolic dysfunction, insulin resistance, PMOS, endometriosis, PMDD, environmental exposures, and symptoms routinely dismissed in women’s care.
The proposed answer is individualized prevention: broader testing, whole-food habits, exercise, sleep and stress management, reduced alcohol, and hormone decisions shaped by personal risk.